Alx Oncology Holdings Inc (ALXO) insider trading.
In Q3 2026, insiders at Alx Oncology Holdings Inc reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $8K.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 3
- Net shares, P minus S
- -4,207
- Insiders
- 2
- Last filed
- 2026-08-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Wong Shelly | Officer · SVP, FINANCE AND CAO | 2 | 0 | 2 |
| Lettmann Jason | Director, Officer · CHIEF EXECUTIVE OFFICER | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-17 | Wong Shelly | S (D) | 573 | $1.93 | 87,828 | Form 4 |
| 2026-08-17 | Lettmann Jason | S (D) | 2,230 | $1.93 | 294,379 | Form 4 |
| 2026-07-01 | Wong Shelly | S (D) | 1,404 | $2.04 | 88,401 | Form 4 |
Transaction codes in this quarter
Get ALXO insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1810182&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ALXO company page · Alx Oncology Holdings Inc on SEC.gov
Questions
Are insiders buying or selling Alx Oncology Holdings Inc (ALXO)?
In Q3 2026, insiders at Alx Oncology Holdings Inc reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $8K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Alx Oncology Holdings Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/alxo.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.